(The Defender) More than 55% of children ranging in age between 6 months and 2 years had a “systemic reaction” after their first dose of the Pfizer-BioNTech or Moderna COVID-19 vaccines, according to data released Sept. 1 by the Centers for Disease Control and Prevention (CDC).
In addition, almost 60% had a reaction to the second dose of the Moderna vaccine, in the CDC survey of more than 13,000 children.
A systemic reaction is a response beyond the injection site.
While the most common systemic reactions were fatigue, fever, irritability and crying, parents of more than 6% of the children in the study said their child was unable to perform normal activities after the second dose of either the Pfizer-BioNTech or Moderna vaccine.
The CDC collected the data through a program called V-Safe — a smartphone-based monitoring system that operates through an app that parents download to their phones.
Between June 18 and Aug. 21, parents of more than 10,000 young children reported reactions to the CDC through V-Safe in the seven days after their child had received a COVID-19 vaccination.
Parents of 8,338 children ages 6 months to 2 years who received the Moderna vaccine reported information through V-Safe, with 55.7% reporting a systemic reaction after the first dose and about 58% after the second dose.
For the Pfizer vaccine, parents of 4,749 children ages 6 months to 2 years submitted reports showing that 55.8% had a systemic reaction after the first dose and about 47% after the second dose of the vaccine.
The most frequently reported reactions for children 6 months to 2 years were irritability or crying, sleepiness and fever. The most common reactions for children aged 3 to 5 years were injection site pain, fatigue and fever.
The data also showed a more serious reaction category labeled “any health impact.”
About 10% of all children 6 months to 2 years were reported to have a “health impact” after getting their first dose of either the Moderna or Pfizer vaccine.
For the Moderna vaccine, slightly more children had a health impact after the second dose; for the Pfizer vaccine, it was slightly less.
The information was presented to the CDC’s Advisory Committee on Immunization Practices on Sept. 1 as part of an overview of all data related to the safety of COVID-19 vaccines.
In addition to V-Safe, data was presented summarizing reports from the Vaccine Adverse Event Reporting System (VAERS) and the Vaccine Safety Data Link (VSD), which includes data from several large health maintenance organizations in the United States.
All three systems look at the safety of vaccines after they’ve already gone to market and have been administered to large numbers of people.
Tom Shimabukuro, the head of the CDC’s vaccine safety team, headed the presentation and told committee members that no “statistical signals” of COVID-19 vaccine reactions were found for young children in the VSD data.
Shimabukuro also said that systemic reactions were “commonly reported” following vaccines.
However, other medical professionals such as Dr. Meryl Nass of Children’s Health Defense have expressed caution over the reported reactions, pointing to the high number of systemic reaction reports among very young children.
She told The Epoch Times on Sept. 2 that she was questioning why the government doesn’t collect and present more information on these cases.
“That stuff is not considered by the CDC to be very important … It’s assumed that all those side effects go away after a few days and leave the people perfectly well,” she said, mentioning the fevers and fatigue.
“Those reactions may, in fact, be harbingers of more serious reactions, but nobody to my knowledge has published anything looking at whether these acute local or systemic reactions are indicators of a later problem.”